342 related articles for article (PubMed ID: 32201176)
1. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
Goldner D; Lavine JE
Gastroenterology; 2020 May; 158(7):1967-1983.e1. PubMed ID: 32201176
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease in Children.
Mann JP; Valenti L; Scorletti E; Byrne CD; Nobili V
Semin Liver Dis; 2018 Feb; 38(1):1-13. PubMed ID: 29471561
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
Satapathy SK; Sanyal AJ
Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease.
Vittorio J; Lavine JE
F1000Res; 2020; 9():. PubMed ID: 32509277
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
Younossi ZM
Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
[TBL] [Abstract][Full Text] [Related]
7. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy.
Petta S; Ting J; Saragoni S; Degli Esposti L; Shreay S; Petroni ML; Marchesini G;
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):1014-1022. PubMed ID: 32423665
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
Cotter TG; Rinella M
Gastroenterology; 2020 May; 158(7):1851-1864. PubMed ID: 32061595
[TBL] [Abstract][Full Text] [Related]
10. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
Zhu C; Zhou D; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
[TBL] [Abstract][Full Text] [Related]
11. How to Approach a Patient With Nonalcoholic Fatty Liver Disease.
Tilg H
Gastroenterology; 2017 Aug; 153(2):345-349. PubMed ID: 28647352
[No Abstract] [Full Text] [Related]
12. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.
Hassan K; Bhalla V; El Regal ME; A-Kader HH
World J Gastroenterol; 2014 Sep; 20(34):12082-101. PubMed ID: 25232245
[TBL] [Abstract][Full Text] [Related]
13. The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease.
Goyal NP; Schwimmer JB
Clin Liver Dis; 2016 May; 20(2):325-38. PubMed ID: 27063272
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
Roeb E; Geier A
Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis.
Li B; Zhang C; Zhan YT
Can J Gastroenterol Hepatol; 2018; 2018():2784537. PubMed ID: 30065915
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies.
Agyapong G; Dashti F; Banini BA
Ann N Y Acad Sci; 2023 Aug; 1526(1):16-29. PubMed ID: 37400359
[TBL] [Abstract][Full Text] [Related]
17. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease.
Tzifi F; Fretzayas A; Chrousos G; Kanaka-Gantenbein C
Hormones (Athens); 2019 Sep; 18(3):255-265. PubMed ID: 31140156
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
Zhou JH; Cai JJ; She ZG; Li HL
World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]